AMRI has completed the relocation of its Bothell, WA research unit into approximately 44,000 sq.-ft. of nearby newly refurbished lab and office space. According to the company, the new facility provides improved operational efficiencies as a result of consolidating all staff and services into one building. The new site has capacity for growth and is currently projected to be double the scale of the current operation during the next five years. The facility is also equipped to support future enhancements in early biology and natural product drug discovery capabilities.

“We are pleased to announce the successful completion of this move that simultaneously positions us to continue to realize margin growth by executing on plans that provide significant cost savings, but that also sets the stage for future growth,” said chairman, chief executive officer and president Thomas E. D’Ambra, Ph.D. “In this current business climate, we believe the pharmaceutical industry will continue to be challenged to simultaneously contain costs while continuing to populate new drug pipelines, resulting in an increased demand for outsourcing services.”